Clinical Trial Update: Mirabegron for the Treatment of Pain Motivated Urinary Frequency and Urgency in Women [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating mirabegron for urinary frequency/urgency in women was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Irritable Syndrome
• Bladder Pain Syndrome
• Urinary Frequency
• Urinary Urgency

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Urinary Frequency/Urgency, Bladder Irritable | Phase 4 | Status: WITHDRAWN